Alterity Therapeutics: Appendix 4C - Q4 FY22 Quarterly Cash Flow Report ...Middle East

Phase 2 clinical trial for ATH434 commences in New Zealand and patient enrolment begins Regulatory approval from the U.K. and Italian regulatory agencies to proceed with the Phase 2 trial A$4.1 million R&D Tax Incentive Scheme refund Cash balance on 30 June 2022 of A$34.8M MELBOURNE,...

Hence then, the article about alterity therapeutics appendix 4c q4 fy22 quarterly cash flow report was published today ( Friday 22/07/2022 - 02:40 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Alterity Therapeutics: Appendix 4C - Q4 FY22 Quarterly Cash Flow Report )

Also on site :

• Ernest James Lattimer arrested for multiple sex crimes involving children who were attending an in-home childcare facility on Emerald Way
• Dunkin' Brings Back Highly Coveted Seasonal Flavor That Fans 'Really Needed Right Now'
• Kohl's Is Selling a Rotating Multicompartment Beauty Organizer That's Decorative and Functional: 'Holds a Lot'